Cargando…
Comparison of urokinase and reteplase thrombolytic treatment in patients with high-risk pulmonary embolism
Thrombolytic treatment is recommended for patients with high-risk pulmonary embolism. The present study compared thrombolytic therapy with urokinase and reteplase. A total of 37 patients presenting with acute high-risk pulmonary embolism at the Intensive Care Unit of Weinan Central Hospital of Shaan...
Autores principales: | Zhang, Yi, Ma, Lan, Fu, Qi, Zhao, Tao, Yan, Rui-Ying, Su, Xing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6880444/ https://www.ncbi.nlm.nih.gov/pubmed/31798706 http://dx.doi.org/10.3892/etm.2019.8153 |
Ejemplares similares
-
Thrombolysis with reteplase in acute pulmonary embolism
por: Nishanth, K.R., et al.
Publicado: (2019) -
Recombinant Expression of Thrombolytic Agent Reteplase in Marine Microalga Tetraselmis subcordiformis (Chlorodendrales, Chlorophyta)
por: Wu, Chunhui, et al.
Publicado: (2021) -
The thrombolytic effect of lumbrokinase is not as potent as urokinase in a rabbit cerebral embolism model.
por: Kim, J. S., et al.
Publicado: (1993) -
Low-dose urokinase thrombolytic therapy for patients with acute intermediate-high-risk pulmonary embolism: A retrospective cohort study
por: Weng, Cuilian, et al.
Publicado: (2021) -
Thrombolytic therapy in submassive pulmonary embolism
por: Özlek, Eda, et al.
Publicado: (2017)